Seeing Is Believing
Currently out of the existing stock ratings of Joel Beatty, 210 are a BUY (73.43%), 62 are a HOLD (21.68%), 14 are a SELL (4.9%).
Analyst Joel Beatty works at BAIRD with a stock forecast success ratio of 50.95% fulfilled within 232.37 days on average.
Joel Beatty’s has documented 558 price targets and ratings displayed on 55 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NRIX, Nurix Therapeutics at 11-Apr-2024.
Analyst best performing recommendations are on LIFE (ATYR PHARMA).
The best stock recommendation documented was for AMAM (AMBRX BIOPHARMA . AMERICAN DEPOSITARY SHARES) at 3/3/2023. The price target of $11 was fulfilled within 3 days with a profit of $4.57 (71.07%) receiving and performance score of 236.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
234
$88.21 (60.50%)
234
27 days ago
0/3 (0%)
$79.61 (51.56%)
Buy
235
$89.21 (61.19%)
235
2 months 3 days ago
2/14 (14.29%)
$85.31 (56.99%)
149
Buy
227
$81.21 (55.70%)
237
2 months 7 days ago
14/22 (63.64%)
$80 (54.42%)
171
Hold
161
$15.21 (10.43%)
171
2 months 7 days ago
2/2 (100%)
$14 (9.52%)
5
Buy
225
$79.21 (54.33%)
250
2 months 7 days ago
2/6 (33.33%)
$78 (53.06%)
435
Which stock is Joel Beatty is most bullish on?
Which stock is Joel Beatty is most reserved on?
What Year was the first public recommendation made by Joel Beatty?